The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides

PloS One
Heidi S SchultzA Sette

Abstract

Immunogenicity is a major concern in drug development as anti-drug antibodies in many cases affect both patient safety and drug efficacy. Another concern is often the limited half-life of drugs, which can be altered by different chemical modifications, like acylation with fatty acids. However, acylation with fatty acids has been shown in some cases to modulate T cell activation. Therefore, to understand the role of acylation with fatty acids on immunogenicity we tested three immunogenic non-acylated peptides and 14 of their acylated analogues for binding to 26 common HLA class II alleles, and their ability to activate T cells in an ex vivo T cell assay. Changes in binding affinity associated with acylation with fatty acids were typically modest, though a significant decrease was observed for influenza HA acylated with a stearic acid, and affinities for DQ alleles were consistently increased. Importantly, we showed that for all three immunogenic peptides acylation with fatty acids decreased their capacity to activate T cells, a trend particularly evident with longer fatty acids typically positioned within the peptide HLA class II binding core region, or when closer to the C-terminus. With these results we have demonstrated that ...Continue Reading

References

Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·J A BerzofskyD J McKean
May 1, 1999·Journal of Autoimmunity·J St LouisG H Strejan
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M GreerE Trifilieff
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·James V Brawley, Patrick Concannon
May 20, 2003·Tissue Antigens·D MiddletonR Komerofsky
Oct 21, 2004·European Journal of Immunology·Clara BuenoJoaquín Madrenas
Jul 16, 2008·Immunology and Cell Biology·Anthony W PurcellPaul A Gleeson
Jul 22, 2009·Advanced Drug Delivery Reviews·Constanze A WeberAnne S De Groot
Feb 9, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·John SidneyAlessandro Sette
Sep 3, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·John SidneyAlessandro Sette
Nov 26, 2010·BMC Bioinformatics·Peng WangBjoern Peters
Sep 29, 2011·British Journal of Pharmacology·Dan Donnelly
Sep 27, 2012·European Journal of Immunology·Rachael J AlmondRebecca J Dearman
Dec 12, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julia HütterBernd Lepenies
Feb 9, 2013·Current Protocols in Immunology·John SidneyAlessandro Sette
Mar 19, 2014·Cancer Immunology, Immunotherapy : CII·Takumi KumaiHiroya Kobayashi
Sep 13, 2015·Journal of Thrombosis and Haemostasis : JTH·J N MahlanguUNKNOWN adept™2 Investigators
May 10, 2017·PloS One·John SidneyAlessandro Sette

❮ Previous
Next ❯

Citations

Dec 24, 2018·Journal of Controlled Release : Official Journal of the Controlled Release Society·Romel Menacho-MelgarMichael D Lynch

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical modifications
acylation
glycosylations

Software Mentioned

Consensus
IEDB
NetMHCIIpan

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.